Novel MicroRNA Reporter Uncovers Repression of Let-7 by GSK-3β

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• let-7 microRNAs function as tumor suppressors by downregulating oncogenic proteins.
• Reduced let-7 levels are observed in various cancers, including ovarian cancer.
• A sensitive assay is needed to systematically measure cellular let-7 levels.

Purpose of the Study:

• To develop and validate a novel let-7 reporter assay system.
• To identify pathways regulating let-7 levels in ovarian cancer cells.
• To evaluate glycogen synthase kinase 3 beta (GSK-3β) as a therapeutic target.

Main Methods:

• Developed a pmirGLO-let7 reporter construct expressing chimeric mRNA with luciferase and let-7 binding sites.
• Transfected ovarian cancer cell lines (BG-1, UCI-101) with the reporter system.
• Screened kinase inhibitors and utilized RNA interference to identify regulators of let-7 activity.

Main Results:

• The pmirGLO-let7 assay showed inverse correlation between luciferase activity and let-7 levels.
• Inhibition or silencing of GSK-3β significantly increased both mature and primary let-7 levels in ovarian cancer cells.
• GSK-3β inhibition led to decreased cell survival and implicated p53 in the regulation of let-7 biosynthesis.

Conclusions:

• GSK-3β plays a critical role in repressing let-7 biosynthesis in ovarian cancer.
• Targeting GSK-3β represents a promising therapeutic strategy for ovarian tumorigenesis.
• The pmirGLO-let7 assay is a valuable tool for studying let-7 regulation.